Investing

Immunome : IMNM

IMNM

Stock Data

$22.73

$0.21 (0.92%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Immunome Inc is a biotechnology firm based in Exton, Pennsylvania, focusing on creating innovative cancer treatments. With a rich portfolio that includes immunotherapies, targeted effectors, radioligand therapies, and antibody drug conjugates (ADCs), the company stands at the forefront of cancer research. Immunome is also known for its cutting-edge memory B cell hybridoma technology, which allows for the rapid screening of novel antibodies and targets, marking a significant stride in the fight against cancer since its inception in 2006.

All Immunome Articles

1 Article

Lee Jackson | Feb 12, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open…